𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Is Chromosome 9 Loss a Marker of Disease Recurrence in Transitional Cell Carcinoma of the Urinary Bladder?

✍ Scribed by Bartlett, J.M.S.; Watters, A.D.; Ballantyne, S.A.; Going, J.J.; Grigor, K.M.; Cooke, T.G.


Book ID
122390591
Publisher
Lippincott Williams and Wilkins
Year
1999
Tongue
English
Weight
124 KB
Volume
161
Category
Article
ISSN
0022-5347

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Loss of heterozygosity on chromosome 9 a
✍ Angela A. G. Van Tilborg; Arnold C. P. Hekman; Kees J. Vissers; Theo H. van der πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 French βš– 106 KB πŸ‘ 2 views

The most frequent genetic aberration found in transitional cell carcinoma (TCC) of the bladder involves chromosome 9. Loss of heterozygosity (LOH) analyses show deletions of both chromosome 9p and 9q, while in situ hybridization studies suggest a significant percentage of tumours with monosomy 9. To

Loss of heterozygosity at chromosome seg
✍ Chan Choi; Mi Hwa Kim; Sang-Woo Juhng; Bong-Ryoul Oh πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 French βš– 107 KB πŸ‘ 1 views

To identify the putative tumor-suppressor gene (TSG) involved in transitional-cell carcinoma (TCC) of the urinary bladder, we undertook an allelotyping analysis in 48 cases of TCC. Relatively high percentages of allelic loss were found in 2p (5 of 23, 21.7%), 8p (9 of 21, 42.9%), 9p (4 of 20, 20.0%)